You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Mifamurtide for the treatment of osteosarcoma

  • Technology appraisal guidance
  • Reference number: TA235
  • Published:  26 October 2011
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Osteosarcoma - mifamurtide: Evidence Review Group critique prepared by School of Health and Related Research (ScHARR), The University of Sheffield

Osteosarcoma - mifamurtide: Evidence Review Group critique prepared by School of Health and Related Research (ScHARR), The University of Sheffield 
Osteosarcoma - mifamurtide: Evidence Review Group critique prepared by School of Health and Related Research (ScHARR), The University of Sheffield
07 September 2011
(254.56 Kb 14 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 06 September 2011

Back to top